Bristol-Myers Sales Beat Estimates, Driven by Heart Drug

(Bloomberg) -- Bristol-Myers Squibb Co.’s blockbuster blood thinner trounced sales estimates in the first quarter, as the company prepares to bring recently acquired Celgene Corp. into the fold.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.